Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy
PaperCitations, authors & open-access status
Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 130 citations, 2021 year and bronze oa status.
130
Citations
2021
Year
bronze
OA Status